A Phase Il of a Therapeutic, Recombinant, Biologically Active HIV-1 Tat Protein Vaccine in HIV-Infected, Anti-Tat Negative, ARV-Treated Adult Volunteers

NCT01513135 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
200
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Barbara Ensoli, MD

Collaborators